Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
New Haven Pharmaceuticals
company
About
New Haven Pharmaceuticals develops prescription pharmaceuticals that utilize drugs or GRAS active pharmaceutical ingredients.
- 11 - 50
Details
- Last Funding Type
- Debt Financing
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications that represent significant market opportunities. The company's novel product pipeline employs proprietary, oral, controlled-release technologies, as well as intellectual property licensed from Yale University, which will enable optimal dosing, safety, efficacy and patient convenience.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
6
$25.17M
New Haven Pharmaceuticals has raised a total of
$25.17M
in funding over 2 rounds. Their latest funding was raised on
Aug 17, 2016 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 17, 2016 | Debt Financing | $602.22K | 1 | — | — | Detail |
| Oct 7, 2015 | Debt Financing | $6.30M | 1 | — | — | Detail |
| Oct 23, 2014 | Series B | $11.78M | 1 | — | — | Detail |
| Dec 31, 2013 | Debt Financing | — | 1 | — | — | Detail |
| Oct 29, 2012 | Series A | $6.49M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
New Haven Pharmaceuticals is funded by 3 investors.
Advantage Capital
and Horizon Technology Finance
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Advantage Capital
|
— | Debt Financing |
Horizon Technology Finance
|
— | Debt Financing |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
